Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

[Analysis of recurrence patterns after curative resection of stage IIIA-N2 non-small cell lung cancer].

Liu JW, Li J, Lin G, Shang XQ.

Zhonghua Yi Xue Za Zhi. 2012 Sep 4;92(33):2314-8. Chinese.

PMID:
23158558
2.

[Prognostic analysis of curative surgery for stage IIIA-N2 non-small cell lung cancer].

Liu JW, Li J, Lin G, Shang XQ.

Zhonghua Zhong Liu Za Zhi. 2013 Jan;35(1):50-3. doi: 10.3760/cma.j.issn.0253-3766.2013.01.011. Chinese.

PMID:
23648301
3.

[Analyses of risk factors for postoperative recurrence after curative resection of stage III A-N2 non-small cell lung cancer].

Qiang G, Guo Y, Xiao F, Yu Q, Liang C, Song Z, Tian Y, Shi B, Liu D.

Zhonghua Yi Xue Za Zhi. 2014 Nov 11;94(41):3239-43. Chinese.

PMID:
25604225
4.

[Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].

Zhang GQ, Han F, Gao SL, A DL, Pang ZL.

Ai Zheng. 2007 May;26(5):519-23. Chinese.

PMID:
17672944
5.

Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.

Nakagiri T, Sawabata N, Funaki S, Inoue M, Kadota Y, Shintani Y, Okumura M.

Interact Cardiovasc Thorac Surg. 2011 May;12(5):733-8. doi: 10.1510/icvts.2010.249896. Epub 2011 Feb 5.

6.

Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials.

Ichinose Y, Kato H, Koike T, Tsuchiya R, Fujisawa T, Shimizu N, Watanabe Y, Mitsudomi T, Yoshimura M; Japan Clinical Oncology Group.

Lung Cancer. 2001 Oct;34(1):29-36.

PMID:
11557110
7.

Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.

Zheng H, Gao W, Fei K, Xie HK, Jiang GN, Ding JA, Li C, Chen C, Zhang L.

Interact Cardiovasc Thorac Surg. 2013 Sep;17(3):447-54. doi: 10.1093/icvts/ivt265. Epub 2013 Jun 19.

8.

Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival.

Varlotto JM, Yao AN, DeCamp MM, Ramakrishna S, Recht A, Flickinger J, Andrei A, Reed MF, Toth JW, Fizgerald TJ, Higgins K, Zheng X, Shelkey J, Medford-Davis LN, Belani C, Kelsey CR.

Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):765-73. doi: 10.1016/j.ijrobp.2014.12.028.

PMID:
25752390
9.

Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.

Iwasaki A, Shirakusa T, Miyoshi T, Hamada T, Enatsu S, Maekawa S, Hiratsuka M.

Thorac Cardiovasc Surg. 2006 Feb;54(1):42-6.

PMID:
16485188
10.

Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.

Taylor MD, Lapar DJ, Thomas CJ, Persinger M, Stelow EB, Kozower BD, Lau CL, Jones DR.

Ann Thorac Surg. 2013 Oct;96(4):1163-70. doi: 10.1016/j.athoracsur.2013.04.031. Epub 2013 Aug 30.

PMID:
23998409
11.

[Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].

Wei WD, Wen ZS, Su XD, Lin P, Rong TH, Chen LK.

Ai Zheng. 2007 Nov;26(11):1231-6. Chinese.

PMID:
17991324
12.

Long-term survival after complete mediastinal lymph node resection and lobectomy in patients with bulky N2 non-small cell lung cancer.

Sakuraba M, Takahashi N, Oh S, Miyasaka Y, Inagaki T, Suzuki K.

Ann Thorac Cardiovasc Surg. 2011;17(2):124-9.

PMID:
21597408
13.

[Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].

Liu K, Chen HL, You QS, Huang JF, Wang H.

Ai Zheng. 2009 Jul;28(7):725-9. Chinese.

PMID:
19624899
14.

Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.

Okada M, Sakamoto T, Yuki T, Mimura T, Nitanda H, Miyoshi K, Tsubota N.

J Thorac Cardiovasc Surg. 2005 Apr;129(4):825-30.

15.

Local recurrence after surgery for non-small cell lung cancer: a recursive partitioning analysis of multi-institutional data.

Kelsey CR, Higgins KA, Peterson BL, Chino JP, Marks LB, D'Amico TA, Varlotto JM.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):768-773.e1. doi: 10.1016/j.jtcvs.2013.05.041. Epub 2013 Jul 13.

16.

The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.

Amini A, Correa AM, Komaki R, Chang JY, Tsao AS, Roth JA, Swisher SG, Rice DC, Vaporciyan AA, Lin SH.

Ann Thorac Surg. 2012 Sep;94(3):914-20. doi: 10.1016/j.athoracsur.2012.04.088. Epub 2012 Jul 21.

17.

Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.

Wang CL, Li Y, Yue DS, Zhang LM, Zhang ZF, Sun BS.

World J Surg. 2012 Feb;36(2):455-62. doi: 10.1007/s00268-011-1360-8.

PMID:
22187129
18.

Failure rates and patterns of recurrence in patients with resected N1 non-small-cell lung cancer.

Varlotto JM, Medford-Davis LN, Recht A, Flickinger JC, Schaefer E, DeCamp MM.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):353-9. doi: 10.1016/j.ijrobp.2010.05.022. Epub 2010 Aug 21.

PMID:
20732754
19.

The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement.

Sawyer TE, Bonner JA, Gould PM, Foote RL, Deschamps C, Trastek VF, Pairolero PC, Allen MS, Shaw EG, Marks RS, Frytak S, Lange CM, Li H.

Cancer. 1997 Oct 15;80(8):1399-408.

PMID:
9338463
20.

[Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].

Li Y, Sun BS, Zhang ZF, Zhang LM, Wang CL.

Zhonghua Yi Xue Za Zhi. 2011 Jun 28;91(24):1682-6. Chinese.

PMID:
21914316
Items per page

Supplemental Content

Write to the Help Desk